Commercially available transfection reagents and negative control siRNA are not inert
Kleefeldt JM, Pozarska A, Nardiello C, Pfeffer T, Vadász I, Herold S, Seeger W, Morty RE
Anal Biochem 2020 Oct 1;606:113828. doi: 10.1016/j.ab.2020.113828
Acute kidney injury and urinary biomarkers in hospitalized patients with coronavirus disease-2019
Husain-Syed F, Wilhelm J, Kassoumeh S, Birk HW, Herold S, Vadász I, Walmrath HD, Kellum JA, Ronco C, Seeger W
Nephrol Dial Transplant 2020 Jul 1;35(7):1271-1274. doi: 10.1093/ndt/gfaa162
Platon: identification and characterization of bacterial plasmid contigs in short-read draft assemblies exploiting protein sequence-based replicon distribution scores
Schengers O, Barth P, Falgenhauer L, Hain T, Chakraborty T, Goesmann A
Microbial Genomics 2020 doi 10.1099/mgen.0.000398
Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus
Skevaki C, Fragkou PC, Cheng C, Xie M, Renz H
J Infect 2020 doi.org/10.1016/j.jinf.2020.06.039
J Cyst Fibros 2021;20:140-148. doi.org/10.1016/j.jcf.2020.05.006
Chillappagari S, Garapati V, Mahavadi P, Naehrlich L, Schmeck BT, Schmitz ML, Guenther A
2020-06-11
Eur Respir Rev 2020 29: 200126; DOI: 10.1183/16000617.0126-2020
Korfei M, MacKenzie B, Meiners S
2020
Cyclophilin Inhibitors Restrict Middle East Respiratory Syndrome Coronavirus Via Interferon λ In Vitro And In Mice
Sauerhering L, Kupke A, Meier L, Dietzel E, Hoppe J, Gruber AD, Gattenloehner S, Witte B, Fink L, Hofmann N, Zimmermann T, Goesmann A, Nist A, Stiewe T, Becker S, Herold S, Peteranderl C
ERJ 2020; DOI: 10.1183/13993003.01826-2019
Using Experimental Models to Identify Pathogenic Pathways and Putative Disease Management Targets in Bronchopulmonary Dysplasia
Morty R
Neonatology doi:10.1159/000506989
Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives
Nelson P, Rath BA, Fragkou P, Antalis E, Tsiodras S, Skevaki C on behalf of the ESCMID Study Group for Respiratory Viruses (ESGREV)
Front Cell Infect Microbiol 2020 10:181
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D, Sampaziotis F, Worlock KB, Yoshida M, Barnes JL & HCA Lung Biological Network
Nature Medicine 2020 26,681-687
Evidence for Overlapping and Distinct Biological Activities and Transcriptional Targets Triggered by Fibroblast Growth Factor Receptor 2b Signaling between Mid- and Early Pseudoglandular Stages of Mouse Lung Development
Jones M, Lingampally A, Wu J, Sedighi J, Ahmadvand N, Wilhelm J, Vazquez-Armendariz I, Herold S, Chen C, Zhang JS, Bellusci S, Chao CM
Cells 2020 9:1274
Failure to Down-Regulate miR-154 Expression in Early Postnatal Mouse Lung Epithelium Suppresses Alveologenesis, with Changes in Tgf-β Signaling Similar to those Induced by Exposure to Hyperoxia
Chao CM, Carraro G, Rako ZA, Kolck J, Sedighi J, Zimmermann V, Moiseenko A, Wilhelm J, Young BM, Chong L, Wu J, Contreras A, Minoo P, Barreto G, Warburton D, Bellusci S
Cells 2020 Apr 2;9(4). pii: E859. doi: 10.3390/cells9040859
Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development
Balz K, Trassl L, Härtel V, Nelson PP, Skevaki C
Front Immunol 11:513. doi: 10.3389/fimmu.2020.00513
Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol
Müller C, Obermann W, Schulte FW, Lange-Grünweller K, Oesterreich L, Elgner F, Glitscher M, Hildt E, Singh K, Wendel H-G, Hartmann RK, Ziebuhr J, Grünweller A
Antiviral Res 2020 175:104706, doi.org/10.1016/j.antiviral.2020.104706
Toward a universal flu vaccine
Herold S, Sander LE
Science 2020 376(6480): 852-53 doi: 10.1126/science.aba2754
